GNPX
Genprex, Inc. Common StockRecent alerts on GNPX
All signals →
SEC filing
GNPX Reports Positive Clinical Data for Reqorsa Gene Therapy, Biomarkers Trop-2 and PTEN Correlate with Prolonged PFS in NSCLC Patients
7d ago
SEC filing
GNPX Press Release: PM Gene Therapy Reverses Hyperglycemia in T2D Mice, 4-Week Complete Rescue, Endoscopic Delivery Potential
35d ago
Insider trade
Sale by Brent M Longnecker
47d ago
Scanner
Unusual buy pressure (3.3x avg, 62% up-volume, +17.9% / +0.33 intraday, above VWAP)
99d ago
SEC filing
GNPX Receives Favorable Patent Decisions in Japan and Europe for REQORSA Gene Therapy in Cancer Treatment Combinations
99d ago
SEC filing
GNPX Announces IP Australia Patent Acceptance for REQORSA Gene Therapy Combination, Expands Acclaim-3 Clinical Trial Sites
112d ago
News
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
147d ago
Get push alerts for GNPX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS